Curasan to launch hyaluronic acid product to treat spinal facet syndrome

Written by Alan Condon | October 01, 2019 | Print  |

German orthobiologics company curasan AG will launch Spinevisc at the German Orthopedic and Traumatology Congress in Berlin from Oct. 22 to 25.

Three insights:

1. Spinevisc is a biomimetic hyaluronic acid product to treat spinal facet joint arthrosis.

2. The product has a medium molecular weight similar to the body's synovial fluids.

3. The company hopes Spinevisc will open new distribution channels and reach new target groups such as spine surgeons, interventional pain therapists and neuroradiologists.

More articles on bilogics:
Dr. Isaac Karikari: Changing attitudes toward opioids and how physicians can drive change
Dr. Timothy Kremchek to operate on Reds rookie Nick Senzel — 4 insights
Icotec to introduce new pedicle screw system — 4 insights 

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers